According to the results of a study of Li et al., PD-L1 was more likely to be expressed on immune cells in regards to tumor cells and the prevalence of PD-L1 was found to express in similar rates on primary and metastatic TNBC samples [25]. This evidence concerns the gene CD274 and neoplasm.